EGFR/ERK signaling has been shown to drive CLDN18 transcription, while increased CLDN18 expression can, in turn, activate ERK1/2, forming a feedforward loop that enhances tumor cell proliferation and invasion, particularly in CCA.34 The gene discussed is CLDN18; the disease is cholangiocarcinoma.